Related Experiment Video
Updated: Aug 10, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England
Daniel Bradshaw1, Arham Khawar2, Poorvi Patel2
1UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK; National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London W2 1NY, UK.
Objectives:
HTLV-1 is predominantly a sexually-transmitted infection but testing is not mentioned in HIV-PrEP guidelines. We ascertained HTLV-1/HTLV-2 seroprevalence amongst HIV-PrEP users in England.
Methods:
An unlinked anonymous seroprevalence study.
Results:
Amongst 2015 HIV-PrEP users, 95% were men, 76% of white ethnicity and 83% had been born in Europe. There were no HTLV-1/HTLV-2 seropositive cases (95% confidence interval 0% - 0.18%).
Conclusions:
There were no HTLV positive cases, likely reflecting the demographic of mostly white and European-born individuals. Similar studies are needed worldwide to inform public health recommendations for HIV-PrEP using populations, particularly in HTLV-endemic settings.
More Related Videos
Related Concept Videos
Sexually Transmitted Infections
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Retrovirus Life Cycles

